Literature DB >> 10093856

Adenosquamous carcinoma of the lung. Surgical results compared with squamous cell and adenocarcinoma.

J Y Hsia1, C Y Chen, C P Hsu, S E Shai, P Y Wang.   

Abstract

The outcome of surgery for adenosquamous carcinoma of the lung in 39 patients treated in 1982-1996 was compared with results in squamous cell carcinoma and adenocarcinoma. Adenosquamous carcinoma comprised only 4.2% of all 914 resected primary lung cancers. The cumulative 5-year postoperative survival rate was 22.6% for the adenosquamous tumours. Comparison of survival curves with those for squamous cell carcinoma and adenocarcinoma indicated non-significant differences. The incidence of lymph-node metastasis was significantly higher in the patients with adenosquamous carcinoma than in the other patient groups.

Entities:  

Mesh:

Year:  1999        PMID: 10093856     DOI: 10.1080/14017439950142000

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  11 in total

1.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: risk of coexistent double cancer.

Authors:  Hidetaka Uramoto; Sohsuke Yamada; Takeshi Hanagiri
Journal:  J Cardiothorac Surg       Date:  2010-10-29       Impact factor: 1.637

3.  Clinical characteristics and prognosis of patients with lung adenosquamous carcinoma after surgical resection: results from two institutes.

Authors:  Lewei Zhu; Long Jiang; Jie Yang; Weiquan Gu; Jianxing He
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods.

Authors:  Xiaohua Shi; Huanwen Wu; Junliang Lu; Huanli Duan; Xuguang Liu; Zhiyong Liang
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

5.  Treatment for Patients With Early Stage Adenosquamous Lung Cancer.

Authors:  Jiaxi He; Shuben Li; Hui Pan; Jianxing He
Journal:  JTO Clin Res Rep       Date:  2020-03-04

6.  Prognostic factors of T2aN0M0 (T3-4cmN0M0, stage IB) non-small-cell lung cancer after surgery: Single-center real-world research.

Authors:  Lei Liu; Jiaqi Zhang; Guige Wang; Ke Zhao; Chao Guo; Yeye Chen; Cheng Huang; Shanqing Li
Journal:  Thorac Cancer       Date:  2021-11-03       Impact factor: 3.500

7.  Clinical Outcomes of Different Generations of EGFR Tyrosine Kinase Inhibitors in Advanced Lung Adenosquamous Carcinoma.

Authors:  Minjuan Hu; Bo Zhang; Jianlin Xu; Shuyuan Wang; Yiming Zhao; Lele Zhang; Baohui Han
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

8.  Clinical characteristics and prognostic significance of 92 cases of patients with primary mixed-histology lung cancer.

Authors:  Pengbo Deng; Chengping Hu; Lihua Zhou; Yuanyuan Li; Li Huang
Journal:  Mol Clin Oncol       Date:  2013-06-14

9.  Clinicopathological characteristics and survival outcomes in adenosquamous carcinoma of the lung: a population-based study from the SEER database.

Authors:  Jian Wang; Bi Lian; Ling Ye; Jie Hu; Yuanlin Song
Journal:  Oncotarget       Date:  2017-12-21

10.  A nomogram to predict prognosis of patients with lung adenosquamous carcinoma: a population-based study.

Authors:  Jiaqi Liang; Qihai Sui; Yuansheng Zheng; Guoshu Bi; Zhencong Chen; Ming Li; Yiwei Huang; Tao Lu; Cheng Zhan; Weigang Guo
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.